prednisone has been researched along with Pemphigoid, Bullous in 130 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Pemphigoid, Bullous: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 138 consecutive patients with bullous pemphigoid were included and were grouped according to the treatment they received: methotrexate, prednisone, a combination of both, or topical glucocorticoids (for mild disease)." | 7.74 | A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. ( Berg, P; Eriksson, H; Kjellman, P, 2008) |
| "Prednisone alone or in combination with an immunosuppressive drug is usually effective in controlling bullous pemphigoid." | 7.70 | Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. ( Albertioni, F; Heilborn, JD; Peterson, C; Ståhle-Bäckdahl, M; Stephansson, E; Vassilaki, I, 1999) |
| "The aim of this study was to evaluate the efficacy of low-dose methotrexate as a steroid-sparing agent in patients with bullous pemphigoid." | 7.69 | Low-dose methotrexate treatment in elderly patients with bullous pemphigoid. ( Fleischer, AB; Jorizzo, JL; Paul, MA; White, WL, 1994) |
| "Eight hospitalized patients with active bullous pemphigoid were treated with high-dose intravenous methylprednisolone pulse therapy followed by moderate maintenance doses of oral prednisone." | 7.67 | High-dose methylprednisolone in the treatment of bullous pemphigoid. ( Eaglstein, WH; Siegel, J, 1984) |
| "Prednisolone (PO) was assayed using high-performance liquid chromatography (HPLC)." | 6.67 | Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. ( Chosidow, O; Diquet, B; Etienne, SD; Herson, S; Puech, AJ; Vandermeersch, V; Vu-Thi-My-Le, C, 1991) |
| "Clobetasol propionate cream applied over the whole body is probably similarly effective as, and may cause less mortality than, oral prednisone for treating bullous pemphigoid." | 5.41 | Interventions for bullous pemphigoid. ( Anchan, VN; Boyle, RJ; Chi, CC; Kirtschig, G; Murrell, DF; Singh, S; Taghipour, K, 2023) |
| "Among the 188 patients with extensive bullous pemphigoid, topical corticosteroids were superior to oral prednisone (P=0." | 5.10 | A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. ( Bedane, C; Benichou, J; Bernard, P; D'Incan, M; Delaporte, E; Dreno, B; Joly, P; Picard, C; Plantin, P; Roujeau, JC; Vaillant, L; Young, P, 2002) |
| "A 41-year-old white man was treated for bullous pemphigoid (BP) for 4 years, using high-dose prednisone as well as ciclosporin and mycophenolate mofetil." | 3.85 | Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin. ( Ahmed, AR; Nguyen, T, 2017) |
| " Hypertension, head involvement, and metformin therapy were found to be significantly associated with the need for adjuvant therapy to achieve initial control, suggesting that these parameters may serve as predictors of treatment response in BP." | 3.85 | Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center. ( Geller, S; Kremer, N; Sprecher, E; Zeeli, T, 2017) |
| "A total of 138 consecutive patients with bullous pemphigoid were included and were grouped according to the treatment they received: methotrexate, prednisone, a combination of both, or topical glucocorticoids (for mild disease)." | 3.74 | A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. ( Berg, P; Eriksson, H; Kjellman, P, 2008) |
| "We describe four patients with generalized bullous pemphigoid, who received treatment with oral prednisone and suffered serious corticosteroid-induced iatrogenesis." | 3.73 | [Replacing systemic with topical corticotherapy in patients with generalized bullous pemphigoid and serious steroid-induced iatrogenesis]. ( Conde, A; Cruces, MJ; García-Doval, I; Mayo, E, 2006) |
| "We present the first reported case of disseminated cytomegalovirus (CMV) in association with prednisone therapy in bullous pemphigoid (BP)." | 3.72 | Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. ( Aoki, V; Casals, DS; Correa, MC; Leite, OH; Maruta, CW; Nunes, Ede A; Rivitti, EA; Santi, CG; Simonsen Nico, MM, 2003) |
| "Prednisone alone or in combination with an immunosuppressive drug is usually effective in controlling bullous pemphigoid." | 3.70 | Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. ( Albertioni, F; Heilborn, JD; Peterson, C; Ståhle-Bäckdahl, M; Stephansson, E; Vassilaki, I, 1999) |
| "The aim of this study was to evaluate the efficacy of low-dose methotrexate as a steroid-sparing agent in patients with bullous pemphigoid." | 3.69 | Low-dose methotrexate treatment in elderly patients with bullous pemphigoid. ( Fleischer, AB; Jorizzo, JL; Paul, MA; White, WL, 1994) |
| "A 87-year-old woman with bullous pemphigoid was treated with long-term prednisone and developed a skin infection due to M." | 3.69 | [Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. ( Bordet, AL; De Muret, A; François-Ramanantsoa, C; Lorette, G; Machet, L; Vaillant, L, 1997) |
| "Eight hospitalized patients with active bullous pemphigoid were treated with high-dose intravenous methylprednisolone pulse therapy followed by moderate maintenance doses of oral prednisone." | 3.67 | High-dose methylprednisolone in the treatment of bullous pemphigoid. ( Eaglstein, WH; Siegel, J, 1984) |
| "Severe cases of pemphigus vulgaris should be treated with prednisone in high dosage (180-360 mg daily)." | 3.67 | [Therapy of pemphigus and pemphigoid]. ( Schaumburg-Lever, G, 1986) |
| "Bullous pemphigoid is an autoimmune skin disease that results in formation of pruritic blisters." | 2.72 | Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature. ( Reedy, M; Saleh, M; Torok, H; Weaver, J, 2021) |
| "Prednisolone (PO) was assayed using high-performance liquid chromatography (HPLC)." | 2.67 | Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. ( Chosidow, O; Diquet, B; Etienne, SD; Herson, S; Puech, AJ; Vandermeersch, V; Vu-Thi-My-Le, C, 1991) |
| "PD-1/PD-L1 inhibitor-induced bullous pemphigoid (BP) is a rare but potentially serious dermatologic toxicity associated with checkpoint inhibitorsIn patients with pruritus or rash that is refractory to topical steroids, physicians should have a greater index of suspicion for higher-grade cutaneous immune-related adverse events." | 2.58 | A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management. ( Geskin, L; Lopez, AT, 2018) |
| "Bullous pemphigoid is the most common autoimmune bullous disease in the West." | 2.43 | Interventions for bullous pemphigoid. ( Hollis, S; Khumalo, N; Kirtschig, G; Middleton, P; Murrell, D; Wojnarowska, F, 2005) |
| "Bullous pemphigoid is the most common autoimmune bullous disease in the West." | 2.42 | Interventions for bullous pemphigoid. ( Hollis, S; Khumalo, N; Kirtschig, G; Middleton, P; Murrell, D; Wojnarowska, F, 2003) |
| "The target antigens in cicatricial pemphigoid appear to be lamina lucida proteins involved in human keratinocyte adhesion to extracellular matrix." | 2.40 | Cicatricial pemphigoid (benign mucous membrane pemphigoid). ( Bergfeld, WF; Terezhalmy, GT, 1998) |
| "Bullous pemphigoid is rarely seen in adolescence, and its presentation, clinical course, and treatment can differ to that found in other age groups." | 1.62 | Bullous pemphigoid in adolescence, a rare demographic. ( Brown, H; Jenkins, D; Lamrock, E, 2021) |
| "Bullous pemphigoid is a common autoimmune blistering disorder, characterized by sub-epidermal bullae formation, that tends to affect older patients." | 1.56 | [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB]. ( Molho-Pessach, V; Neumark, M; Tal, Y; Zlotogorski, A, 2020) |
| "Bullous pemphigoid is the most common autoimmune bullous disease, treated with low dosage local or systemic corticosteroids." | 1.43 | [BULLOUS PEMPHIGOID RESISTANT TO CORTICOSTEROIDS]. ( Cohen, E; Rozenman, D; Sah, M; Ziv, M, 2016) |
| "Bullous pemphigoid is a rare, autoimmune blistering disease." | 1.38 | "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin. ( Filipe, P; Lopes, L; Marques, MS; Pacheco, D; Soares-Almeida, L, 2012) |
| " Increasing the dosage of oral steroid and minocycline resulted in relief of bullous pemphigoid, although patchy skin pigmentation remained especially in the irradiated skin." | 1.37 | A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. ( Isohashi, F; Koizumi, M; Konishi, K; Tanei, T; Umegaki, N; Yoshioka, Y, 2011) |
| "Several variants of bullous pemphigoid have been reported including pemphigoid nodularis." | 1.37 | Pemphigoid nodularis: a case report. ( Kalaaji, AN; Lehman, JS; Rogers, RS; Stone, RA, 2011) |
| " Furthermore, patients with BP positive for IgE anti-BP180 Abs required longer duration for remission, higher dosage of prednisolone, and more intensive therapies for remission." | 1.35 | Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. ( Hara, T; Iwata, Y; Kodera, M; Komura, K; Muroi, E; Ogawa, F; Sato, S; Takenaka, M; Usuda, T; Yokoyama, Y, 2008) |
| " All patients responded with complete remission of symptomatology and had a prednisone dosage reduction until 70%." | 1.32 | Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. ( Da Ponte, C; De Roia, D; Guerra, R; Mazzi, G; Orazi, BM; Raineri, A; Santarossa, L; Zanolli, FA, 2003) |
| " All patients went into remission with a lower daily dosage of oral prednisone at 3 and 6 months postplasmapheresis." | 1.31 | Plasmapheresis as a steroid saving procedure in bullous pemphigoid. ( Egan, CA; Meadows, KP; Zone, JJ, 2000) |
| "We describe the clinical presentation, treatment of Kaposi's sarcoma skin lesions in an immunosuppressed patient with bullous pemphigoid." | 1.30 | Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. ( Gaspari, AA; Marchese, S; Powell, D; Rady, PL; Tyring, SK, 1997) |
| "Dapsone was stopped on day 15 due to poor hematological tolerance." | 1.30 | [Sporadic superficial pemphigus in the child: 2 cases]. ( Bourrat, E; Ducloy, G; Flageul, B; Moraillon, I; Morel, P; Reymond, JL; Rybojad, M; Vignon-Pennamen, MD, 1999) |
| "Acute vesicular or weeping dermatoses are best treated with cool, wet compresses and topical lotions, whereas dry, scaly skin conditions should be treated with hydrating measures and topical ointments." | 1.27 | Dermatologic emergencies. ( Rapini, RP, 1986) |
| "Bullous pemphigoid is an autoimmune bullous dermatosis that can be preceded by a prodromal phase, usually lasting weeks to months, during which the cutaneous changes are dermatitic rather than bullous." | 1.27 | The prodrome of bullous pemphigoid. ( Amato, DA; Silverstein, J; Zitelli, J, 1988) |
| "Bullous pemphigoid is a chronic blistering disorder characterized by specific clinical, histologic, and immunofluorescent findings." | 1.27 | Bullous pemphigoid and prurigo nodularis. ( Dahl, MV; Roenigk, RK, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (19.23) | 18.7374 |
| 1990's | 23 (17.69) | 18.2507 |
| 2000's | 32 (24.62) | 29.6817 |
| 2010's | 39 (30.00) | 24.3611 |
| 2020's | 11 (8.46) | 2.80 |
| Authors | Studies |
|---|---|
| Huynh, LM | 1 |
| Bonebrake, BT | 1 |
| DiMaio, DJ | 1 |
| Baine, MJ | 1 |
| Teply, BA | 1 |
| Liang, S | 1 |
| Cohen, J | 1 |
| Soter, N | 1 |
| Zhou, X | 1 |
| Zhou, Y | 1 |
| Qian, H | 1 |
| Wu, F | 1 |
| Liu, H | 1 |
| Li, X | 1 |
| Li, W | 1 |
| Singh, S | 1 |
| Kirtschig, G | 5 |
| Anchan, VN | 1 |
| Chi, CC | 1 |
| Taghipour, K | 1 |
| Boyle, RJ | 1 |
| Murrell, DF | 3 |
| Agarwal, A | 1 |
| Falcone, LM | 1 |
| James, AJ | 1 |
| Mani, H | 1 |
| Safo, P | 1 |
| Onitilo, AA | 1 |
| Lee, J | 1 |
| Seiffert-Sinha, K | 1 |
| Attwood, K | 1 |
| Sinha, AA | 1 |
| Neumark, M | 1 |
| Tal, Y | 1 |
| Zlotogorski, A | 1 |
| Molho-Pessach, V | 1 |
| Morris, LM | 1 |
| Lewis, HA | 1 |
| Cornelius, LA | 1 |
| Chen, DY | 1 |
| Rosman, IS | 1 |
| Sartor, E | 1 |
| Sernicola, A | 1 |
| Silvestre, C | 1 |
| Neri, F | 1 |
| Alaibac, M | 1 |
| Brown, H | 1 |
| Lamrock, E | 1 |
| Jenkins, D | 1 |
| Saleh, M | 1 |
| Reedy, M | 1 |
| Torok, H | 1 |
| Weaver, J | 1 |
| Hébert, V | 1 |
| Bastos, S | 1 |
| Drenovska, K | 1 |
| Meijer, J | 1 |
| Ingen-Housz-Oro, S | 2 |
| Bedane, C | 2 |
| Lunardon, L | 1 |
| Debarbieux, S | 1 |
| Jedlickova, H | 1 |
| Caux, F | 1 |
| Chaby, G | 1 |
| D'Incan, M | 2 |
| Feliciani, C | 1 |
| Boulard, C | 1 |
| Schumacher, N | 1 |
| Schmidt, E | 1 |
| Roussel, A | 1 |
| Richard, MA | 1 |
| Gottlieb, J | 1 |
| Ferranti, V | 1 |
| Guérin, O | 1 |
| Bénichou, J | 2 |
| Joly, P | 6 |
| Nguyen, T | 1 |
| Ahmed, AR | 2 |
| Sah, M | 1 |
| Rozenman, D | 1 |
| Cohen, E | 1 |
| Ziv, M | 1 |
| Nakazato, S | 1 |
| Ujiie, H | 1 |
| Inamura, Y | 1 |
| Nishimura, M | 1 |
| Iwata, H | 1 |
| Shimizu, H | 1 |
| Kremer, N | 1 |
| Zeeli, T | 1 |
| Sprecher, E | 1 |
| Geller, S | 1 |
| Amber, KT | 1 |
| Valdebran, M | 1 |
| Lu, Y | 1 |
| De Feraudy, S | 1 |
| Linden, KG | 1 |
| Lopez, AT | 1 |
| Geskin, L | 1 |
| Kalinska-Bienias, A | 1 |
| Kowalczyk, E | 1 |
| Jagielski, P | 1 |
| Kowalewski, C | 2 |
| Wozniak, K | 2 |
| Patsatsi, A | 1 |
| Kyriakou, A | 1 |
| Werth, VP | 1 |
| Sánchez López-Muelas, B | 1 |
| Muray Cases, S | 1 |
| Illán Gómez, F | 1 |
| García Guzmán, G | 1 |
| Arjonilla Sampedro, ME | 1 |
| Maglie, R | 1 |
| Antiga, E | 1 |
| Quintarelli, L | 1 |
| Verdelli, A | 1 |
| Caproni, M | 2 |
| Hall, RP | 1 |
| Streilein, RD | 1 |
| Hannah, DL | 1 |
| McNair, PD | 1 |
| Fairley, JA | 1 |
| Ronaghy, A | 1 |
| Edhegard, KD | 1 |
| Levesque, MC | 1 |
| Woo, SB | 1 |
| Stone, JH | 1 |
| Kraft, S | 1 |
| Mael-ainin, M | 1 |
| El Morabite, K | 1 |
| Hassam, B | 1 |
| Senouci, K | 1 |
| Shafran, DM | 1 |
| Bunce, PE | 1 |
| Gold, WL | 1 |
| Marek-Jozefowicz, L | 1 |
| Scibior, K | 1 |
| Czajkowski, R | 1 |
| Carlos, G | 1 |
| Anforth, R | 1 |
| Chou, S | 1 |
| Clements, A | 1 |
| Fernandez-Peñas, P | 1 |
| Seminario-Vidal, L | 1 |
| Sami, N | 1 |
| Miller, J | 1 |
| Theos, A | 1 |
| Imbernón-Moya, A | 1 |
| Aguilar, A | 1 |
| Burgos, F | 1 |
| Gallego, MÁ | 1 |
| Schwartz, RA | 3 |
| Janniger, CK | 1 |
| Harada, K | 1 |
| Iwasaki, A | 1 |
| Kato, Y | 1 |
| Fujii, N | 1 |
| Saito, M | 1 |
| Tsuboi, R | 1 |
| Ayala-Cortés, AS | 1 |
| Martínez-Cabriales, SA | 1 |
| Welsh, O | 1 |
| Rosales-Solis, G | 1 |
| Vázquez-Martínez, O | 1 |
| Ocampo-Candiani, J | 1 |
| Gajic-Veljic, M | 1 |
| Nikolic, M | 1 |
| Medenica, L | 1 |
| Vano-Galvan, S | 1 |
| Carrillo, R | 1 |
| Moreno, C | 1 |
| Jaen, P | 1 |
| Mönkemüller, K | 1 |
| Neumann, H | 1 |
| Fry, LC | 1 |
| Boughrara, Z | 1 |
| Legrand, P | 1 |
| Duong, TA | 1 |
| Roujeau, JC | 5 |
| Middleton, P | 3 |
| Bennett, C | 1 |
| Wojnarowska, F | 5 |
| Khumalo, NP | 2 |
| Bernard, P | 2 |
| Charneux, J | 1 |
| Isohashi, F | 1 |
| Konishi, K | 1 |
| Umegaki, N | 1 |
| Tanei, T | 1 |
| Koizumi, M | 1 |
| Yoshioka, Y | 1 |
| Mammen, C | 1 |
| White, CT | 1 |
| Prendiville, J | 1 |
| Mazzarolo, SS | 1 |
| Guilabert, A | 1 |
| Lozano, F | 1 |
| Iranzo, P | 1 |
| Suárez-Casasús, B | 1 |
| Martinez-De Pablo, I | 1 |
| Julià, M | 1 |
| Mascaró, JM | 1 |
| Munsch, C | 1 |
| Prey, S | 1 |
| Meyer, N | 1 |
| Lamant, L | 1 |
| Livideanu, C | 1 |
| Viraben, R | 1 |
| Paul, C | 1 |
| Li, F | 1 |
| Jin, HZ | 1 |
| Su, F | 1 |
| Jia, L | 1 |
| Sun, QN | 1 |
| Kwatra, SG | 1 |
| Jorizzo, JL | 2 |
| Lehman, JS | 1 |
| Kalaaji, AN | 1 |
| Rogers, RS | 1 |
| Stone, RA | 1 |
| van den Bos, RR | 1 |
| Middelburg, T | 1 |
| van Biezen, P | 1 |
| van der Eijk, AA | 1 |
| Pas, HH | 1 |
| Diercks, GF | 1 |
| Nigam, R | 1 |
| Levitt, J | 1 |
| Pacheco, D | 1 |
| Lopes, L | 1 |
| Soares-Almeida, L | 1 |
| Marques, MS | 1 |
| Filipe, P | 1 |
| Ardern-Jones, MR | 1 |
| Venning, VA | 1 |
| Bystryn, JC | 2 |
| Wainwright, BD | 1 |
| Shupack, JL | 1 |
| Spigel, GT | 1 |
| Breit, R | 1 |
| Mazzi, G | 1 |
| Raineri, A | 1 |
| Zanolli, FA | 1 |
| Da Ponte, C | 1 |
| De Roia, D | 1 |
| Santarossa, L | 1 |
| Guerra, R | 1 |
| Orazi, BM | 1 |
| Casals, DS | 1 |
| Nunes, Ede A | 1 |
| Maruta, CW | 1 |
| Aoki, V | 1 |
| Santi, CG | 1 |
| Simonsen Nico, MM | 1 |
| Correa, MC | 1 |
| Leite, OH | 1 |
| Rivitti, EA | 1 |
| Amato, L | 2 |
| Mei, S | 2 |
| Gallerani, I | 2 |
| Moretti, S | 1 |
| Fabbri, P | 2 |
| Baoxi, W | 1 |
| Xiuqing, D | 1 |
| Ying, Z | 1 |
| Jiabi, W | 1 |
| Khumalo, N | 2 |
| Hollis, S | 2 |
| Murrell, D | 2 |
| Sugimura, C | 1 |
| Katsuura, J | 1 |
| Moriue, T | 1 |
| Matsuoka, Y | 1 |
| Kubota, Y | 1 |
| LEDO, A | 2 |
| ROOK, A | 1 |
| Kreuter, A | 1 |
| Harati, A | 1 |
| Breuckmann, F | 1 |
| Appelhans, C | 1 |
| Altmeyer, P | 1 |
| Jamel, K | 1 |
| Wahiba, K | 1 |
| Youssef, BB | 1 |
| Hassen, J | 1 |
| Monia, K | 1 |
| Narjess, C | 1 |
| Abdelaziz, F | 1 |
| Yamauchi, PS | 1 |
| Lowe, NJ | 1 |
| Gindi, V | 1 |
| García-Doval, I | 1 |
| Conde, A | 1 |
| Mayo, E | 1 |
| Cruces, MJ | 1 |
| Kazandjian, DG | 1 |
| Okulicz, JF | 1 |
| Hashimoto, T | 1 |
| Ishii, N | 1 |
| Glinska-Wielochowska, M | 1 |
| Liu, BG | 1 |
| Li, ZY | 1 |
| Du, M | 1 |
| Iwata, Y | 1 |
| Komura, K | 1 |
| Kodera, M | 1 |
| Usuda, T | 1 |
| Yokoyama, Y | 1 |
| Hara, T | 1 |
| Muroi, E | 1 |
| Ogawa, F | 1 |
| Takenaka, M | 1 |
| Sato, S | 1 |
| Kjellman, P | 1 |
| Eriksson, H | 1 |
| Berg, P | 1 |
| Czernik, A | 1 |
| Patel, HP | 1 |
| Anhalt, GJ | 2 |
| Diaz, LA | 1 |
| Stage, AH | 1 |
| Humeniuk, JM | 1 |
| Easley, WK | 1 |
| Siegel, J | 1 |
| Eaglstein, WH | 1 |
| Scaparro, E | 1 |
| Borghi, S | 1 |
| Rebora, A | 1 |
| George, LW | 1 |
| White, SL | 1 |
| Worm, AM | 1 |
| Rossing, N | 1 |
| Neufeld, R | 1 |
| Portnoy, M | 1 |
| Rodstein, M | 1 |
| Gruber, GG | 1 |
| Owen, LG | 1 |
| Callen, JP | 1 |
| Saurat, JH | 1 |
| Danno, K | 1 |
| Okamoto, H | 1 |
| Miyauchi, H | 1 |
| Imamura, S | 1 |
| Foster, CS | 1 |
| Wilson, LA | 1 |
| Ekins, MB | 1 |
| van der Meeren, H | 1 |
| Lacroix, H | 1 |
| Ochsner, PE | 1 |
| Westerhof, W | 1 |
| Núñez, M | 1 |
| Miralles, ES | 1 |
| Muñoz, E | 1 |
| Paul, MA | 1 |
| Fleischer, AB | 1 |
| White, WL | 1 |
| Marck, Y | 1 |
| Meunier, L | 1 |
| Perez, C | 1 |
| Meynadier, J | 1 |
| Guillaume, JC | 1 |
| Donnard, JC | 1 |
| Schnebelen, MP | 1 |
| Tortel, MC | 1 |
| Michel, C | 1 |
| Grange, F | 1 |
| Enta, T | 1 |
| Sharma, R | 1 |
| Gupta, KL | 1 |
| Ammon, RH | 1 |
| Gambert, SR | 1 |
| Krunic, AL | 1 |
| Kokai, D | 1 |
| Bacetic, B | 1 |
| Kesic, V | 1 |
| Nikolic, MM | 1 |
| Petkovic, S | 1 |
| Clark, RE | 1 |
| Gaspari, AA | 1 |
| Marchese, S | 1 |
| Powell, D | 1 |
| Rady, PL | 1 |
| Tyring, SK | 1 |
| Levine, N | 2 |
| Ginarte, M | 1 |
| Sánchez-Aguilar, D | 1 |
| Pereiro-Ferreirós, MM | 1 |
| Toribio, J | 1 |
| Bordet, AL | 1 |
| Machet, L | 1 |
| De Muret, A | 1 |
| François-Ramanantsoa, C | 1 |
| Lorette, G | 1 |
| Vaillant, L | 2 |
| Nousari, HC | 1 |
| Griffin, WA | 1 |
| Terezhalmy, GT | 1 |
| Bergfeld, WF | 1 |
| Verret, JL | 1 |
| Rybojad, M | 1 |
| Ducloy, G | 1 |
| Reymond, JL | 1 |
| Moraillon, I | 1 |
| Flageul, B | 1 |
| Vignon-Pennamen, MD | 1 |
| Morel, P | 1 |
| Bourrat, E | 1 |
| Heilborn, JD | 1 |
| Ståhle-Bäckdahl, M | 1 |
| Albertioni, F | 1 |
| Vassilaki, I | 1 |
| Peterson, C | 1 |
| Stephansson, E | 1 |
| Hsu, S | 1 |
| Egan, CA | 2 |
| Meadows, KP | 1 |
| Zone, JJ | 1 |
| Yancey, KB | 1 |
| Bhat, L | 1 |
| Sams, HH | 1 |
| King, LE | 1 |
| Pestelli, E | 1 |
| Picard, C | 1 |
| Dreno, B | 1 |
| Delaporte, E | 1 |
| Plantin, P | 1 |
| Young, P | 1 |
| Stern, RS | 1 |
| Cordel, N | 1 |
| Courville, P | 1 |
| Martel, P | 1 |
| Musette, P | 1 |
| Goulon, M | 1 |
| Combes, A | 1 |
| Chesneau, AM | 1 |
| Bournérias, I | 1 |
| Chosidow, O | 4 |
| Saada, V | 1 |
| Diquet, B | 2 |
| Revuz, J | 3 |
| Merchaoui, J | 1 |
| Makhlouf, T | 1 |
| Sfar, R | 1 |
| Mokthar, I | 1 |
| Fazaa, B | 1 |
| Kamoun, MR | 1 |
| Oranje, AP | 1 |
| Vuzevski, VD | 1 |
| van Joost, T | 1 |
| ten Kate, F | 1 |
| Naafs, B | 1 |
| Etienne, SD | 1 |
| Vandermeersch, V | 1 |
| Vu-Thi-My-Le, C | 1 |
| Herson, S | 1 |
| Puech, AJ | 1 |
| Laurent-Puig, P | 1 |
| Prost, C | 1 |
| Espagne, E | 1 |
| Wechsler, J | 1 |
| Trozak, DJ | 1 |
| Laurent-Poig, P | 1 |
| Delchier, JC | 1 |
| Hsu, VM | 1 |
| Krey, PR | 1 |
| Prasad, KK | 1 |
| Chen, L | 1 |
| Rapini, RP | 1 |
| Amato, DA | 1 |
| Silverstein, J | 1 |
| Zitelli, J | 1 |
| Alcalay, J | 1 |
| Sandbank, M | 1 |
| Hombal, SM | 1 |
| Roenigk, RK | 1 |
| Dahl, MV | 1 |
| Dickmann, U | 1 |
| Ritter, G | 1 |
| Kretzschmar, H | 1 |
| Schaumburg-Lever, G | 1 |
| Ducomb, DF | 1 |
| Perry, HO | 1 |
| Goldberg, NS | 1 |
| Robinson, JK | 1 |
| Roenigk, HH | 1 |
| Marder, R | 1 |
| Rothe, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid[NCT02365675] | 12 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | |||
| Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus[NCT00483119] | Phase 2 | 9 participants (Actual) | Interventional | 2007-04-30 | Terminated (stopped due to Study was terminated due to the death of the PI.) | ||
| Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | B cells per microliter (Median) |
|---|---|
| Treated | 3.99 |
IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | Elisa Units (Median) |
|---|---|
| Treated | 40.5 |
The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year
| Intervention | Days (Median) |
|---|---|
| Treated | 57 |
Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks
| Intervention | participants (Number) |
|---|---|
| Treated | 7 |
The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year
| Intervention | participants (Number) | ||
|---|---|---|---|
| Treatment emergent adverse events | Infusion reactions | Disease Progression | |
| Treated | 0 | 0 | 1 |
18 reviews available for prednisone and Pemphigoid, Bullous
| Article | Year |
|---|---|
Interventions for bullous pemphigoid.
Topics: Azathioprine; Clobetasol; Dapsone; Doxycycline; Humans; Methylprednisolone; Niacinamide; Pemphigoid, | 2023 |
Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Drug Resistance; Glucocorticoids; Humans; Inte | 2021 |
A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.
Topics: Aged; Antineoplastic Agents, Immunological; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Clobetaso | 2018 |
Bullous pemphigoid in adolescence.
Topics: Adolescent; Anti-Infective Agents; Azathioprine; Child; Dapsone; Female; Glucocorticoids; Humans; Im | 2019 |
Erythema Multiforme-Like Bullous Pemphigoid.
Topics: Adult; Autoantibodies; Autoantigens; Azathioprine; Biopsy; Collagen Type XVII; Diagnosis, Differenti | 2016 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Clobetasol; Combined Modality Therapy; Drug Therapy, Combination; Drugs, Chinese Herba | 2010 |
[Bullous pemphigoid: a review].
Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug | 2011 |
Childhood bullous pemphigoid: a rare manifestation of chronic renal allograft rejection.
Topics: Biopsy, Needle; Child; Chronic Disease; Diagnosis, Differential; Graft Rejection; Humans; Immunohist | 2011 |
Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Glucocorticoids; Humans; Immunologic Factors; | 2012 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; P | 2003 |
Dyshidrosiform pemphigoid: report of a case.
Topics: Aged; Autoantigens; Biopsy, Needle; Eczema, Dyshidrotic; Enzyme-Linked Immunosorbent Assay; Female; | 2003 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; P | 2005 |
[Pemphigoid gestationis: a pregnancy-related pathology underestimated by obstetricians].
Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Pemphigoid, Bullous; Prednisone; Pregnancy; Pregnanc | 2005 |
Bullous pemphigoid and pemphigus vulgaris.
Topics: Antibody Specificity; Antigen-Antibody Reactions; Autoantibodies; Autoimmune Diseases; Bandages; Bas | 1983 |
Cicatricial pemphigoid (benign mucous membrane pemphigoid).
Topics: Adult; Anti-Infective Agents; Dapsone; Diagnosis, Differential; Epidermolysis Bullosa Acquisita; Fem | 1998 |
Erythrodermic bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Basement Membrane; Humans; Immunoglobulin G; Male | 2001 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
A systematic review of treatments for bullous pemphigoid.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; | 2002 |
[Obstetrical prognosis of gestational pemphigoid. Study of a series of 13 cases and review of the literature].
Topics: Adult; Delivery, Obstetric; Female; Humans; Pemphigoid, Bullous; Prednisone; Pregnancy; Pregnancy Co | 1992 |
4 trials available for prednisone and Pemphigoid, Bullous
| Article | Year |
|---|---|
[Effects of jingui shenqi pill combined prednisone on expression of glucocorticoid receptor and its clinical effect in treating bullous pemphigoid patients].
Topics: Aged; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glucocorticoids; Humans; Immunohisto | 2006 |
[Treatment of bullous pemphigoid: general corticosteroid therapy or local corticosteroid therapy?].
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Humans; Pemphigoid, Bullous; | 1999 |
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Topics: Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Clobetasol; Glucocorticoids; | 2002 |
Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; | 1991 |
108 other studies available for prednisone and Pemphigoid, Bullous
| Article | Year |
|---|---|
Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Doxycycline; Drug-Related Side Ef | 2021 |
The Use of Mycophenolate Mofetil in the Treatment of Bullous Pemphigoid.
Topics: Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigoid, Bullous; | 2022 |
Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
Topics: Autoantibodies; Autoantigens; Humans; Pemphigoid, Bullous; Piperidines; Prednisone; Pyrimidines | 2023 |
Methotrexate-induced hypersensitivity pneumonitis in a patient with bullous pemphigoid.
Topics: Alveolitis, Extrinsic Allergic; Drug Hypersensitivity; Humans; Methotrexate; Pemphigoid, Bullous; Pr | 2023 |
Linagliptin-associated bullous pemphigoid treated with rituximab.
Topics: Aged; Anti-Bacterial Agents; Clobetasol; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Humans; | 2019 |
A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Female; Humans; Immunosuppressive Agents; Male; Middle Ag | 2019 |
[EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].
Topics: Aged; Anti-Allergic Agents; Antibodies, Monoclonal; Autoimmune Diseases; Humans; Male; Omalizumab; P | 2020 |
Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Topics: Aged; Antimalarials; Dapsone; Drug Eruptions; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2020 |
Bullous pemphigoid and renal graft rejection: is there a causative link?
Topics: Adult; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplant | 2020 |
Bullous pemphigoid in adolescence, a rare demographic.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Betamethasone; Female; Glucocorti | 2021 |
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged, 80 and over; Humans; Pemphigoid, Bullous; Predn | 2021 |
Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
Topics: Adult; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunos | 2017 |
[BULLOUS PEMPHIGOID RESISTANT TO CORTICOSTEROIDS].
Topics: Adrenal Cortex Hormones; Aged; Cyclophosphamide; Drug Resistance; Female; Hospitalization; Humans; P | 2016 |
A case of bullous pemphigoid presenting with severe oedema of the hands during recurrence.
Topics: Aged; Anti-Inflammatory Agents; Edema; Hand; Humans; Male; Pemphigoid, Bullous; Prednisone; Recurren | 2017 |
Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diabetes Mellitus; | 2017 |
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
Topics: Administration, Oral; Administration, Topical; Aged, 80 and over; Antibodies, Monoclonal, Humanized; | 2018 |
Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clobetasol; Drug Therapy, | 2019 |
Bullous pemphigoid associated with linagliptin treatment in diabetic patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Humans; Hypoglycemic Ag | 2019 |
Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab.
Topics: Humans; Immunologic Factors; Male; Middle Aged; Omalizumab; Pemphigoid, Bullous; Prednisone; Rituxim | 2019 |
Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Cell Activating Factor; Blister; Enz | 2013 |
Case Records of the Massachusetts General Hospital: Case 22-2013: A 51-year-old woman with epistaxis and oral mucosal ulcers.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Diagnosis, Differential; Epistaxis; Fem | 2013 |
[Infantile bullous pemphigoid. Report of a new case].
Topics: Administration, Oral; Biopsy; Child, Preschool; Diagnosis, Differential; Female; Humans; Pemphigoid, | 2014 |
Reducing the risk of infection in a 74-year-old man who is to receive prednisone.
Topics: Aged; Glucocorticoids; Hepatitis B, Chronic; Humans; Lamivudine; Latent Tuberculosis; Male; Pemphigo | 2014 |
PUVA induced bullous pemphigoid in a patient with psoriasis.
Topics: Female; Glucocorticoids; Humans; Middle Aged; Pemphigoid, Bullous; Prednisone; Psoriasis; PUVA Thera | 2014 |
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Dexamethas | 2015 |
Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
Topics: Anti-Bacterial Agents; Clindamycin; Dapsone; Diagnosis, Differential; Drug Resistance; Humans; Immun | 2015 |
Topical high potency steroid proclaimed optimal therapy for bullous pemphigoid in the elderly.
Topics: Aged; Glucocorticoids; Humans; Pemphigoid, Bullous; Prednisone | 2017 |
Cytomegalovirus oral ulcers in a patient with bullous pemphigoid.
Topics: Aged, 80 and over; Antiviral Agents; Cytomegalovirus; Female; Ganciclovir; Glucocorticoids; Humans; | 2016 |
Childhood Bullous Pemphigoid: A Treatment Challenge.
Topics: Adolescent; Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Male; Methotrexate; Pemphigo | 2016 |
Juvenile bullous pemphigoid: the presentation and follow-up of six cases.
Topics: Adolescent; Child; Child, Preschool; Dapsone; Female; Fluocinolone Acetonide; Follow-Up Studies; Hum | 2010 |
Bullous dermatosis. Bullous pemphigoid.
Topics: Aged, 80 and over; Female; Fluorescent Antibody Technique; Glucocorticoids; Humans; Immunoglobulin G | 2009 |
Esophageal blebs and blisters.
Topics: Aged; Biopsy; Blister; Endoscopy, Digestive System; Esophageal Diseases; Esophagus; Humans; Male; Pe | 2010 |
[Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Aged; Cellulitis; Diabetes Complications; Diseas | 2010 |
A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy.
Topics: Acute Disease; Breast Neoplasms; Carcinoma, Ductal, Breast; Dose Fractionation, Radiation; Drug Admi | 2011 |
Blistering eruption on the leg of an adult.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blister; Ciprofloxacin; Dermatitis Herpetiformis; D | 2011 |
A case of aggressive bullous pemphigoid associated with the defective functional variant of Fc gamma receptor IIb: implications for pathogenesis?
Topics: Aged; Alleles; Autoantibodies; Autoantigens; Azathioprine; Collagen Type XVII; Cyclophosphamide; Dap | 2011 |
[Anti-p200 pemphigoid: a spectacular response to dapsone].
Topics: Aged, 80 and over; Antibody Specificity; Autoantibodies; Autoantigens; Clobetasol; Complement C3; Da | 2011 |
Pneumocystis pneumonia in patients with immunobullous dermatoses.
Topics: Aged; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middl | 2011 |
Bullous pemphigoid: a case series with emphasis on long-term remission off therapy.
Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male | 2013 |
Pemphigoid nodularis: a case report.
Topics: Aged; Antimetabolites; Azathioprine; Diagnosis, Differential; Female; Fluorescent Antibody Technique | 2011 |
Orf-induced pemphigoid with antilaminin-332 antibodies.
Topics: Anti-Inflammatory Agents; Autoantibodies; Cell Adhesion Molecules; Ecthyma, Contagious; Female; Fluo | 2012 |
"Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
Topics: Azathioprine; Blister; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; M | 2012 |
Oral and topical corticosteroids in bullous pemphigoid.
Topics: Administration, Oral; Administration, Topical; Glucocorticoids; Humans; Pemphigoid, Bullous; Prednis | 2002 |
Oral and topical corticosteroids in bullous pemphigoid.
Topics: Administration, Oral; Administration, Topical; Adsorption; Clobetasol; Glucocorticoids; Humans; Pemp | 2002 |
Oral and topical corticosteroids in bullous pemphigoid.
Topics: Administration, Oral; Administration, Topical; Clobetasol; Drug Costs; Glucocorticoids; Humans; Pemp | 2002 |
[A startling beginning! Revolutionary local therapy of bullous pemphigoid?].
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Clobetasol; Cost Control; Diagnosis-Related | 2002 |
Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
Topics: Aged; Combined Modality Therapy; Disease Management; Female; Humans; Immunosuppressive Agents; Male; | 2003 |
Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy.
Topics: Aged; Biopsy, Needle; Cytomegalovirus Infections; Fever; Follow-Up Studies; Ganciclovir; Humans; Imm | 2003 |
A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid?
Topics: Adult; Chronic Disease; Diagnosis, Differential; Disease Progression; Female; Fluorescent Antibody T | 2003 |
A retrospective study of 60 hospitalized cases with pemphigoid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Glucocorticoids; Humans; Hydrocortisone; | 2000 |
[PEMPHIGOID. ITS RELATIONSHIP WITH OTHER BULLOUS ERUPTIONS].
Topics: Dermatitis Herpetiformis; Dermatology; Diagnosis, Differential; Erythema Multiforme; Geriatrics; Hum | 1964 |
Intravenous immune globulin in the treatment of persistent pemphigoid gestationis.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immuno | 2004 |
Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
Topics: Anti-Inflammatory Agents; Comorbidity; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agent | 2006 |
[Replacing systemic with topical corticotherapy in patients with generalized bullous pemphigoid and serious steroid-induced iatrogenesis].
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Amputation, Surgical; Clobetasol; Comorbidity; D | 2006 |
Skin tears?
Topics: Aged; Anti-Bacterial Agents; Antipruritics; Clobetasol; Female; Humans; Hydroxyzine; Immunosuppressi | 2006 |
Penicillin-induced anti-p200 pemphigoid: an unusual morphology.
Topics: Autoantibodies; Autoimmune Diseases; Erythema; Female; Humans; Immunoglobulin G; Methotrexate; Middl | 2006 |
Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Topics: Aged; Autoantibodies; Autoantigens; Biomarkers; Case-Control Studies; Collagen Type XVII; Enzyme-Lin | 2008 |
A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Glucoco | 2008 |
Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
Topics: Aged; Autoantibodies; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunoglobuli | 2008 |
Bullous pemphigoid of the vulva: a case report.
Topics: Aged; Female; Humans; Pemphigoid, Bullous; Prednisone; Skin Diseases, Vesiculobullous; Vulvar Diseas | 1984 |
High-dose methylprednisolone in the treatment of bullous pemphigoid.
Topics: Aged; Blister; Drug Administration Schedule; Female; Fluorescent Antibody Technique; Humans; Immunos | 1984 |
Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid.
Topics: Aged; Humans; Immunosuppression Therapy; Male; Pemphigoid, Bullous; Prednisone; Sarcoma, Kaposi; Ski | 1984 |
Autoimmune skin disease of large animals.
Topics: Animals; Aurothioglucose; Autoimmune Diseases; Biopsy; Diagnosis, Differential; Female; Horse Diseas | 1984 |
Microvascular protein leakage in extensive skin diseases: aspects of the transport mechanisms.
Topics: Adult; Aged; Albumins; Biological Transport; Capillary Permeability; Dermatitis, Atopic; Dermatitis, | 1980 |
Bullous pemphigoid in a one hundred year old woman.
Topics: Aged; Female; Humans; Pemphigoid, Bullous; Prednisone; Skin Diseases, Vesiculobullous | 1980 |
Vesicular pemphigoid.
Topics: Dermatitis Herpetiformis; Diagnosis, Differential; Female; Humans; Middle Aged; Pemphigoid, Bullous; | 1980 |
[Bullous pemphigoid in children (author's transl)].
Topics: Child, Preschool; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Pemphigoid, Bull | 1982 |
Bullous pemphigoid and antinuclear antibodies. Unmasking of basement membrane fluorescence in sodium chloride-treated substrates.
Topics: Animals; Antibodies, Antinuclear; Basement Membrane; Binding Sites, Antibody; Complement C3; Dapsone | 1982 |
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid.
Topics: Adult; Aged; Azathioprine; Cicatrix; Conjunctival Diseases; Corneal Diseases; Cyclophosphamide; Drug | 1982 |
Multifocal hematogenous osteomyelitis in an adult treated with corticosteroids.
Topics: Female; Humans; Immunosuppression Therapy; Leg; Middle Aged; Osteomyelitis; Pemphigoid, Bullous; Pre | 1982 |
[Bullous pemphigoid and multiple sclerosis].
Topics: Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Pemphigoid, Bullous; Prednisone; T | 1995 |
Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Combinations; Female; Humans; Male; Methotrexate | 1994 |
[Primary cutaneous nocardia asteroides nocardiosis in an immunocompromised patient].
Topics: Aged; Humans; Immunocompromised Host; Leg Dermatoses; Male; Nocardia asteroides; Nocardia Infections | 1995 |
[Local corticosteroid therapy in a severe form of pemphigoid gestationis].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Female; Fetal Death; Humans; Pemphigoid, B | 1996 |
Dermacase. Bullous pemphigoid.
Topics: Age Distribution; Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Male; Middle Aged; Pemp | 1997 |
Atypical presentation of colon perforation related to corticosteroid use.
Topics: Aged; Aged, 80 and over; Colonic Diseases; Diverticulum, Colon; Female; Glucocorticoids; Humans; Int | 1997 |
Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption.
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Azathioprine; Diagnosis, Differential; Fe | 1997 |
Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Azathioprine; DNA, Viral; Female; Herpesvirus 8, Human; Humans; Immunosuppr | 1997 |
Blistering eruption on the abdomen.
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Diagnosis, Differential; Humans; Male; Pemphigo | 1997 |
Pemphigus vulgaris exhibiting Koebner phenomenon.
Topics: Alkylating Agents; Anti-Inflammatory Agents; Burns; Cyclophosphamide; Fluorescent Antibody Technique | 1998 |
[Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Glucocorticoids; Humans; Imm | 1997 |
Successful therapy for bullous pemphigoid with mycophenolate mofetil.
Topics: Aged; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophen | 1998 |
[Sporadic superficial pemphigus in the child: 2 cases].
Topics: Adult; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Female; Fluor | 1999 |
Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Dermatologic Agents; Exudates and Transudates | 1999 |
A perplexing case of pruritic plaques. Bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Humans; Male; Pemphigoid, Bullous; Prednisone; Pr | 2000 |
Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoantigens; Azathioprine; Carrier Protei | 2000 |
Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Basement Membrane; Female; Glucocortic | 2000 |
Vesicles on the extremities. Patients who spend time outside may be especially prone to these lesions in the summer.
Topics: Aged; Arm; Dermatitis, Toxicodendron; Diagnosis, Differential; Female; Herpes Simplex; Humans; Insec | 2001 |
Bullous pemphigoid associated with Castleman disease.
Topics: Bone Marrow Examination; Castleman Disease; Diabetes Mellitus, Type 2; Diagnosis, Differential; Eryt | 2001 |
Bullous pemphigoid therapy -- think globally, act locally.
Topics: Administration, Oral; Administration, Topical; Autoimmune Diseases; Clobetasol; Glucocorticoids; Hum | 2002 |
Extensive erosive bullous pemphigoid: an atypical and serious clinical variant.
Topics: Aged; Aged, 80 and over; Cyclosporine; Diabetes Complications; Drug Therapy, Combination; Fatal Outc | 2002 |
[Polyradiculopathy associated with bullous pemphigoid (author's transl)].
Topics: Aged; Azathioprine; Dermatitis Herpetiformis; Diagnosis, Differential; Humans; Male; Pemphigoid, Bul | 1979 |
Correlation between the pretreatment number of blisters and the time to control bullous pemphigoid with prednisone 1 mg/kg/day.
Topics: Aged; Aged, 80 and over; Drug Administration Schedule; Female; Humans; Male; Pemphigoid, Bullous; Pr | 1992 |
Bullous pemphigoid in children. Report of three cases with special emphasis on therapy.
Topics: Adolescent; Autoimmune Diseases; Child; Drug Therapy, Combination; Erythromycin; Humans; Male; Niaci | 1991 |
[Bullous pemphigoid secondary corticoresistant. Inhibitory role of omeprazole on corticosteroid metabolism?].
Topics: Adult; Drug Interactions; Drug Resistance; Female; Humans; Microsomes, Liver; Omeprazole; Pemphigoid | 1991 |
Bullous pemphigoid and multiple sclerosis.
Topics: Adult; Humans; Male; Multiple Sclerosis; Pemphigoid, Bullous; Prednisone; Skin Diseases, Vesiculobul | 1990 |
[Possibility of prednisone-omeprazole interference in bullous pemphigoid].
Topics: Adult; Drug Interactions; Female; Humans; Omeprazole; Pemphigoid, Bullous; Prednisone; Recurrence; U | 1990 |
Bullous pemphigoid and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Biopsy; Female; Hand Deformities, Acquired; Humans; Middle Aged; Pemphigoid, | 1989 |
Anesthetic management of a patient with bullous pemphigoid.
Topics: Anesthesia, Spinal; Azathioprine; Female; Humans; Injections, Spinal; Middle Aged; Pemphigoid, Bullo | 1989 |
Dermatologic emergencies.
Topics: Aged; Dermatitis, Contact; Dermatitis, Exfoliative; Emergencies; Erythema; Histamine H1 Antagonists; | 1986 |
The prodrome of bullous pemphigoid.
Topics: Aged; Azathioprine; Biopsy; Dermatitis; Female; Fluorescent Antibody Technique; Humans; Middle Aged; | 1988 |
Localized chronic pemphigoid as an unusual cause of circulatory eosinophilia.
Topics: Aged; Chronic Disease; Eosinophilia; Female; Humans; Male; Pemphigoid, Bullous; Prednisone; Scalp De | 1987 |
Cicatricial pemphigoid.
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Aged; Female; Fluorescent Antibody Technique; Huma | 1986 |
Bullous pemphigoid and prurigo nodularis.
Topics: Aged; Dapsone; Female; Fluorescent Antibody Technique; Humans; Immunoglobulins; Pemphigoid, Bullous; | 1986 |
[Pemphigoid and cerebral infarct. Syntropy of 2 diseases? Case report].
Topics: Aged; Cerebral Infarction; Electroencephalography; Female; Humans; Pemphigoid, Bullous; Prednisone; | 1986 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous | 1986 |
Chronic blisters on aging skin: causes and treatment.
Topics: Aged; Aging; Chronic Disease; Complement C3; Diagnosis, Differential; Humans; Immunoglobulin G; Immu | 1985 |
Plasmapheresis therapy for bullous pemphigoid.
Topics: Aged; Female; Humans; Pemphigoid, Bullous; Plasma Exchange; Plasmapheresis; Prednisone; Skin Disease | 1985 |